This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Oxford Biotherapeutics Ltd, Medarex Inc.. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 18 
1 out of 152 
Years Active: 2013-2018
Title: Innovations by Erika Meaddough
Introduction
Erika Meaddough is an accomplished inventor based in Gilroy, California. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment. With a total of two patents to her name, her work has the potential to impact the lives of many patients suffering from various forms of cancer.
Latest Patents
One of Erika's latest patents involves antibodies that bind to the extracellular domain of the Tyrosine-protein kinase transmembrane receptor Matriptase. This invention provides not only the antibodies but also nucleic acid molecules encoding them, expression vectors, and host cells for their production. These antibodies may be utilized in the treatment of several cancers, including gastric, colorectal, prostate, breast, ovarian, lung, esophageal, head and neck, pancreatic cancers, lymphoma, and skin cancer.
Another significant patent focuses on fully human antibodies specific to CADM1. This disclosure includes isolated monoclonal antibodies, particularly engineered antibodies that exhibit increased binding to Fc receptors and enhanced potency for antibody-dependent cellular cytotoxicity (ADCC) or immunoconjugates. The patent also covers nucleic acid molecules encoding CADM1 antibodies, expression vectors, host cells, and methods for their expression. Furthermore, it provides methods for detecting CADM1 and treating various cancers, including lung and pancreatic cancer.
Career Highlights
Erika has worked with notable companies in the biotechnology sector, including Oxford Biotherapeutics Ltd and Medarex Inc. Her experience in these organizations has contributed to her expertise in developing innovative therapeutic solutions.
Collaborations
Erika has collaborated with several professionals in her field, including Jonathan Alexander Terrett and Chetana Rao-Naik. These collaborations have likely enriched her research and development efforts.
Conclusion
Erika Meaddough's contributions to the field of biotechnology through her innovative patents demonstrate her commitment to advancing cancer treatment. Her work continues to pave the way for new therapeutic options that could benefit countless patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile